Cargando…
Maca against Echinococcosis?—A Reverse Approach from Patient to In Vitro Testing
Drug-based treatment of alveolar echinococcosis (AE) with benzimidazoles is in most cases non-curative, thus has to be taken lifelong. Here, we report on a 56-year-old male AE patient who received standard benzimidazole treatment and biliary plastic stents, and additionally self-medicated himself wi...
Autores principales: | Karpstein, Tanja, Chaudhry, Sheena, Bresson-Hadni, Solange, Hayoz, Michael, Boubaker, Ghalia, Hemphill, Andrew, Rufener, Reto, Kaethner, Marc, Schindler, Isabelle, Aebi, Yolanda, Cunha, Antonio Sa, Largiadèr, Carlo R., Lundström-Stadelmann, Britta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537204/ https://www.ncbi.nlm.nih.gov/pubmed/34684284 http://dx.doi.org/10.3390/pathogens10101335 |
Ejemplares similares
-
Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014) -
The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis
por: Lundström-Stadelmann, Britta, et al.
Publicado: (2019) -
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis
por: Lundström-Stadelmann, Britta, et al.
Publicado: (2020) -
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis
por: Stadelmann, Britta, et al.
Publicado: (2016) -
Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds
por: Ritler, Dominic, et al.
Publicado: (2017)